Tango Therapeutics (TNGX) Times Interest Earned (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Times Interest Earned of -$0.16 for Q1 2026, up 99.99% year-over-year from -$0.08 in Q1 2025, and up 77.44% quarter-over-quarter from -$0.69 in Q4 2025.
Tango Therapeutics (TNGX) Times Interest Earned (2020 - 2026) Analysis & Trends
Tango Therapeutics' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.16 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 99.99% year-over-year to -$0.16; the TTM figure through Mar 2026 stood at -$0.37 (up 99.99% YoY), while the FY2025 annual figure was -$0.6, up 35.93% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.16, up from -$0.69 in the prior quarter.
- The five-year high for Times Interest Earned was $0.24 in Q3 2025, with the low at -$1575.2 in Q1 2025.
- The 5-year median for Times Interest Earned is -$0.38 (2022), against an average of -$94.15.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned slumped 343973.55% in 2024, then soared 123.45% in 2025.
- Tango Therapeutics' Times Interest Earned stood at -$0.38 in 2022, then tumbled by 48.2% to -$0.56 in 2023, then plunged by 3292.91% to -$18.96 in 2024, then soared by 96.36% to -$0.69 in 2025, then surged by 77.44% to -$0.16 in 2026.
- Business Quant data shows TNGX's Times Interest Earned at -$0.16 in Q1 2026, -$0.69 in Q4 2025, and $0.24 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | -0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.69 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | -1.97 |
| Mar 31, 2025 | -1,575.19 |
| Dec 31, 2024 | -18.96 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -0.69 |
| Mar 31, 2024 | -1.14 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.44 |
| Sep 30, 2021 | 0.00 |